Paper Details

  1. Home
  2. Paper Details

Antiviral agents for treatment of herpes simplex virus infection in neonates.

Author: BadawiNadia, JonesCheryl A, WalkerKaren S

Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
Meta-AnalysisA statistical technique that integrates the results of multiple studies to draw more general conclusions about a particular issue.
ReviewAn article that critically examines existing research on a particular topic and summarizes the current state of knowledge in the field.
Systematic ReviewA review that systematically collects, evaluates, and integrates relevant research to answer a specific research question.

Overview

Herpes simplex virus (HSV) infection is a rare but serious condition in newborns. Before antiviral medications were available, the death rate was high for all but localized infections, with 85% of babies with widespread HSV dying within a year, and 50% of babies with brain infection also dying. Survivors of widespread HSV infection often had long-term neurological problems.
Paper Details　
Original Abstract of the Article :
Herpes simplex virus (HSV) is a rare but serious neonatal pathogen. Prior to the availability of antiviral drugs the mortality associated with all but localised neonatal infection was high, with 85% of infants with disseminated HSV infection and 50% of infants with encephalitis dying by one year of ...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7101052/

データ提供：米国国立医学図書館（NLM）

A Battle Against Herpes Simplex Virus: A Tale of Hope

The world of [neonatal medicine] often presents daunting challenges, and this study delves into one such battle: the treatment of herpes simplex virus (HSV) infection in newborns. The authors present a captivating narrative of the progress made in this field, highlighting the transformative impact of antiviral drugs. This research takes us on a journey through time, revealing the once-grim mortality rates associated with HSV infection and the remarkable shift brought about by the advent of these life-saving therapies.

Hope on the Horizon: A Glimpse into the Future of Neonatal Care

This study highlights the profound impact of antiviral drugs on neonatal outcomes. The dramatic reduction in mortality and long-term neurological sequelae associated with HSV infection is a testament to the advancements in medical science. This research offers a beacon of hope for families facing this challenging diagnosis, underscoring the importance of early diagnosis and treatment for optimal outcomes.

A Reminder of the Power of Medical Innovation: A Journey of Progress

This study underscores the remarkable progress made in the treatment of neonatal HSV infection. It serves as a powerful reminder of the ongoing evolution of medical science and its ability to transform the lives of vulnerable patients. This research inspires hope for the future of neonatal care, highlighting the potential for continued innovation and improved outcomes for infants facing a multitude of medical challenges.

Dr. Camel's Conclusion

This study reminds us of the remarkable progress made in medicine, particularly in the realm of neonatal care. The development of antiviral drugs has significantly transformed the outlook for infants battling herpes simplex virus infection, offering a brighter future for those facing this challenging diagnosis.

Date :
  1. Date Completed 2009-08-14
  2. Date Revised 2021-10-20
Further Info :

Pubmed ID

19588350

DOI: Digital Object Identifier

PMC7101052

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.